238 related articles for article (PubMed ID: 15571183)
21. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites.
Zaak D; Paquet KJ; Kuhn R
Z Gastroenterol; 2001 Jan; 39(1):5-10. PubMed ID: 11215366
[TBL] [Abstract][Full Text] [Related]
22. Peritoneal dialysis in the comprehensive management of end-stage renal disease patients with liver cirrhosis and ascites: practical aspects and review of the literature.
Selgas R; Bajo MA; Del Peso G; Sánchez-Villanueva R; Gonzalez E; Romero S; Olivas E; Hevia C
Perit Dial Int; 2008; 28(2):118-22. PubMed ID: 18332443
[TBL] [Abstract][Full Text] [Related]
23. Bioimpedance analysis and intradialytic hypotension in intermittent hemodialysis.
Koziolek MJ; Gauczinski S; Kahler E; Bramlage CP; Scheel AK; Mueller GA; Strutz F
Clin Nephrol; 2006 Jul; 66(1):39-50. PubMed ID: 16878434
[TBL] [Abstract][Full Text] [Related]
24. A case of peritoneal-extracorporeal shunting for refractory hemodialysis ascites.
Hida M; Takamiya T; Iida T; Kitajima N; Hiraga S; Satoh T
Tokai J Exp Clin Med; 1987 May; 12(2):79-81. PubMed ID: 3449987
[No Abstract] [Full Text] [Related]
25. Characterization of treatment dose delivered by albumin dialysis in the treatment of acute renal failure associated with severe hepatic dysfunction.
McIntyre CW; Fluck RJ; Freeman JG; Lambie SH
Clin Nephrol; 2002 Nov; 58(5):376-83. PubMed ID: 12425489
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic improvement after peritoneovenous shunting in nephrogenic ascites.
Morgan AG; Sivapragasam S; Fletcher P; Terry SI
South Med J; 1982 Mar; 75(3):373-4. PubMed ID: 7063919
[TBL] [Abstract][Full Text] [Related]
27. Treatment time, chronic inflammation, and hemodynamic stability: the overlooked parameters in hemodialysis quantification.
Zsom L; Zsom M; Fulop T; Flessner MF
Semin Dial; 2008; 21(5):395-400. PubMed ID: 18945325
[TBL] [Abstract][Full Text] [Related]
28. Nephrogenic ascites. Analysis of 16 cases and review of the literature.
Han SH; Reynolds TB; Fong TL
Medicine (Baltimore); 1998 Jul; 77(4):233-45. PubMed ID: 9715728
[TBL] [Abstract][Full Text] [Related]
29. Development of refractory ascites during amiodarone therapy in a hemodialysis patient with nephrogenic and cardiogenic ascites.
Wang JY; Hwang B; Lin YF; Chen JD
Ren Fail; 2012; 34(8):1033-6. PubMed ID: 22880809
[TBL] [Abstract][Full Text] [Related]
30. Applications and outcome of hemodialysis in cats: a review of 29 cases.
Langston CE; Cowgill LD; Spano JA
J Vet Intern Med; 1997; 11(6):348-55. PubMed ID: 9470160
[TBL] [Abstract][Full Text] [Related]
31. Changing acute renal failure treatment from intermittent hemodialysis to continuous hemofiltration: impact on azotemic control.
Bellomo R; Farmer M; Bhonagiri S; Porceddu S; Ariens M; M'Pisi D; Ronco C
Int J Artif Organs; 1999 Mar; 22(3):145-50. PubMed ID: 10357242
[TBL] [Abstract][Full Text] [Related]
32. Renal replacement therapy in end-stage renal disease patients with chronic liver disease and ascites: role of peritoneal dialysis.
Chaudhary K; Khanna R
Perit Dial Int; 2008; 28(2):113-7. PubMed ID: 18332442
[TBL] [Abstract][Full Text] [Related]
33. Survival after acute kidney injury requiring dialysis: long-term follow up.
Duran PA; Concepcion LA
Hemodial Int; 2014 Oct; 18 Suppl 1():S1-6. PubMed ID: 25330825
[TBL] [Abstract][Full Text] [Related]
34. Factors determining a low dose of haemodialysis as measured by ionic dialysance in critical patients with acute kidney injury.
Rosa-Diez G; Greloni G; Crucelegui M; Bedini-Roca M; Heredia-Martínez A; Coli ML; Giannasi S; San-Román E; Pizarro R; Belzitti C; Algranati S; Heguilen R
Nefrologia; 2012 May; 32(3):359-66. PubMed ID: 22535160
[TBL] [Abstract][Full Text] [Related]
35. Verification of serum albumin elevating effect of cell-free and concentrated ascites reinfusion therapy for ascites patients: a retrospective controlled cohort study.
Yamada Y; Inui K; Hara Y; Fuji K; Sonoda K; Hashimoto K; Kamijo Y
Sci Rep; 2019 Jul; 9(1):10195. PubMed ID: 31308465
[TBL] [Abstract][Full Text] [Related]
36. Management of refractory ascites using nocturnal home hemodialysis.
Pauly RP; Sood MM; Chan CT
Semin Dial; 2008; 21(4):367-70. PubMed ID: 18573138
[TBL] [Abstract][Full Text] [Related]
37. Comparison of spontaneous ascites filtration and reinfusion with total paracentesis with intravenous albumin infusion in cirrhotic patients with tense ascites.
Bruno S; Borzio M; Romagnoni M; Battezzati PM; Rossi S; Chiesa A; Podda M
BMJ; 1992 Jun; 304(6843):1655-8. PubMed ID: 1633517
[TBL] [Abstract][Full Text] [Related]
38. Ascites in a patient undergoing maintenance hemodialysis.
Kes P; Ratković-Gusić I; Sefer S
Acta Med Croatica; 1997; 51(1):57-61. PubMed ID: 9115105
[TBL] [Abstract][Full Text] [Related]
39. Nephrogenic ascites: a poorly understood syndrome.
Hammond TC; Takiyyuddin MA
J Am Soc Nephrol; 1994 Nov; 5(5):1173-7. PubMed ID: 7873726
[TBL] [Abstract][Full Text] [Related]
40. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
Ifudu O; Feldman J; Friedman EA
N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
